The human factor H protein family - an update

Front Immunol. 2024 Feb 12:15:1135490. doi: 10.3389/fimmu.2024.1135490. eCollection 2024.

Abstract

Complement is an ancient and complex network of the immune system and, as such, it plays vital physiological roles, but it is also involved in numerous pathological processes. The proper regulation of the complement system is important to allow its sufficient and targeted activity without deleterious side-effects. Factor H is a major complement regulator, and together with its splice variant factor H-like protein 1 and the five human factor H-related (FHR) proteins, they have been linked to various diseases. The role of factor H in inhibiting complement activation is well studied, but the function of the FHRs is less characterized. Current evidence supports the main role of the FHRs as enhancers of complement activation and opsonization, i.e., counter-balancing the inhibitory effect of factor H. FHRs emerge as soluble pattern recognition molecules and positive regulators of the complement system. In addition, factor H and some of the FHR proteins were shown to modulate the activity of immune cells, a non-canonical function outside the complement cascade. Recent efforts have intensified to study factor H and the FHRs and develop new tools for the distinction, quantification and functional characterization of members of this protein family. Here, we provide an update and overview on the versatile roles of factor H family proteins, what we know about their biological functions in healthy conditions and in diseases.

Keywords: Factor H; age-related macular degeneration; cancer; complement alternative pathway; factor H-related proteins; infection; inflammation; kidney disease.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement Activation
  • Complement Factor H* / metabolism
  • Complement System Proteins*
  • Humans

Substances

  • CFH protein, human
  • Complement Factor H
  • Complement System Proteins

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The work of the authors was supported in part by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 899163 (SciFiMed), the Kidneeds Foundation (Iowa, US), the National Research, Development and Innovation (NRDI) Office (PharmaLab National Laboratory, RRF-2.3.1-21-2022-00015), the NRDI Fund of Hungary (OTKA grant K 125219), the Ministry for Innovation and Technology from the Hungarian NRDI Fund (2020-1.1.6-JÖVŐ-2021-00010), the Hungarian Academy of Sciences and the Hungarian Research Network (0106307), and by project no. FIEK_16-1-2016-0005, implemented with the support provided from the NRDI Fund of Hungary, financed under the FIEK_16 funding scheme.